The Impact of a Novel GnRH Antagonist With Add-back Therapy for Treatment of Uterine Fibroids and Endometriosis on Hemostasis Parameters

Abroad (travel likely)Recruiting

Conditions

Uterine Fibroid

Simple summaryAI-assisted

This summary is produced by a language model and is experimental. It may be incomplete or inaccurate and is not a substitute for professional medical advice.

Locations
  • Hôpitaux Universitaires de Genève, Geneva, Canton of Geneva, Switzerland

    Contact: Study coordinator (Sonia Campelo) · sonia.campelo@hug.ch · +41 79 55 35 747
    Contact: Study coordinator (Véronique Othenin-Girard) · veronique.othenin-girard@hug.ch
    Marc Blondon (Sub-investigator)
    Alessandro Casini (Sub-investigator)
    Jean Dubuisson (Sub-investigator)
    Isabelle Streuli (Sub-investigator)
    Justine Hugon-Rodin (Sub-investigator)
Study leads
  • Patrick Petignat, Prof

    Study Director

    University Hospital, Geneva